# Tarsus (TARS) — News

TARS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tars/news

## Recent headlines

- [Al Tajamouat for Touristic Projects - Acquisition as part of commitment to completing its development and expansion plans](https://www.ainvest.com/news/al-tajamouat-touristic-projects-acquisition-part-commitment-completing-development-expansion-plans-2610) — AInvest Wire, Oct 13, 2026
  Al Tajamouat for Touristic Projects Company PSC (TAJM), a Jordan-based public shareholding company operating in the real estate development and operations sector, has recently made a strategic acquisition as part of its ongoing commitment to completing its development and expansion plans. The…
- [Tarsus Pharmaceuticals, Inc.: Barclays reinstates coverage with overweight rating; price target $110](https://www.ainvest.com/news/tarsus-pharmaceuticals-barclays-reinstates-coverage-overweight-rating-price-target-110-2609) — AInvest Wire, Sep 16, 2026
- [Tarsus Pharmaceuticals completes acquisition of Alkeus Pharmaceuticals, expanding leadership in eye care](https://www.ainvest.com/news/tarsus-pharmaceuticals-completes-acquisition-alkeus-pharmaceuticals-expanding-leadership-eye-care-2609) — AInvest Wire, Sep 4, 2026
  Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) has completed its acquisition of Alkeus Pharmaceuticals, Inc., a privately held biotechnology company focused on retinal diseases. The transaction, valued at up to $800 million, includes an upfront payment of $450 million, consisting of $270 million in…
- [Tarsus Pharmaceuticals reports oversubscribed $125M placement](https://www.ainvest.com/news/tarsus-pharmaceuticals-reports-oversubscribed-125m-placement-2608) — AInvest Wire, Aug 6, 2026
- [Tarsus to buy Alkeus for ~$450M upfront in cash and stock](https://www.ainvest.com/news/tarsus-buy-alkeus-450m-upfront-cash-stock-2608) — AInvest Wire, Aug 6, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).